Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Thromb Haemost ; 3(6): 1274-83, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15946218

ABSTRACT

BACKGROUND: RGD is a major recognition sequence for ligands of platelet alpha(IIb)beta3. OBJECTIVE AND METHODS: To identify potential binding sites for alpha(IIb)beta3 apart from RGD, we screened phage display libraries by blocking the enrichment of RGD-containing phages with a GRGDS peptide and identified a novel integrin recognition tripeptide sequence, VPW. RESULTS: Platelets adhered to an immobilized cyclic VPW containing peptide in a alpha(IIb)beta3-dependent manner; platelets and alpha(IIb)beta3-expressing CHO cells adhered faster to immobilized alpha(IIb)beta3-ligands in the presence of soluble VPW. In platelets adhering to fibrinogen, VPW accelerated the activation of the tyrosine kinase Syk which controls cytoskeletal rearrangements. In alpha(IIb)beta3-expressing CHO cells, VPW induced a faster formation of stress fibers. Sequence alignment positioned VPW to V980-P981-W982 in the von Willebrand factor (vWf) A-3 domain. In blood from a vWf-deficient individual, VPW increased platelet adhesion to fibrinogen but not to collagen under flow and rescued the impaired adhesion to vWf deficient in A-3. CONCLUSION: These data reveal a VPW sequence that contributes to alpha(IIb)beta3 activation in in vitro experiments. Whether the V980-P981-W982 sequence in vWf shows similar properties under in vivo conditions remains to be established.


Subject(s)
Fibrinogen/metabolism , Oligopeptides/pharmacology , Platelet Adhesiveness/drug effects , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Signal Transduction , von Willebrand Factor/analogs & derivatives , Amino Acid Sequence , Binding Sites , Blood Platelets , Enzyme Precursors/metabolism , Humans , Intracellular Signaling Peptides and Proteins , Molecular Mimicry , Peptide Fragments/pharmacology , Protein-Tyrosine Kinases/metabolism , Syk Kinase , von Willebrand Diseases/blood , von Willebrand Factor/chemistry , von Willebrand Factor/physiology
2.
J Thromb Haemost ; 1(10): 2216-24, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14521607

ABSTRACT

Platelet integrin alphaIIbbeta3 must be activated via intracellular mechanisms before it binds soluble ligands, and it is thought to be activated at its extracellular site by surface-bound ligands. Integrin activation is associated with rearrangement of the cytoskeleton and phosphorylation of proteins that become localized in focal contacts. In these processes, the cytoplasmic tail of the beta-subunit plays a central role. We introduced peptides homologous to the E749ATSTFTN756 domain (E-N peptide) and the T755NITYRGT762 domain (T-T peptide) of beta3 in streptolysin O-permeabilized platelets and analyzed the initial interaction with soluble fibronectin, fibrinogen and PAC-1 after stimulation with thrombin. E-N peptide left the initial binding of fibronectin intact but interfered with stable receptor occupancy. E-N peptide also inhibited fibrinogen binding, thereby reducing the formation of large aggregates. Strikingly, E-N peptide did not disturb the binding of PAC-1, which is known to reflect activation of the integrin. E-N peptide also inhibited tyrosine phosphorylation of focal adhesion kinase, a response known to be dependent on alphaIIbbeta3. T-T peptide did not affect these processes. In a model for outside-in integrin activation, E-N peptide disrupted the binding of CHO cells expressing alphaIIbbeta3 to surface-bound ligand. Again, T-T peptide had no effect. We conclude that the E749ATSTFTN756 region of the beta3-tail stabilizes the binding of soluble and surface-bound ligand to integrin alphaIIbbeta3 via a mechanism that involves the phosphorylation of FAK.


Subject(s)
Platelet Glycoprotein GPIIb-IIIa Complex/chemistry , Animals , Blood Platelets/cytology , Blood Platelets/metabolism , CHO Cells , Cell Line , Cricetinae , Cytoplasm/metabolism , Cytoskeleton/metabolism , Fibrinogen/chemistry , Fibronectins/chemistry , Fibronectins/metabolism , Focal Adhesion Kinase 1 , Focal Adhesion Protein-Tyrosine Kinases , Humans , Ligands , Peptides/chemistry , Phosphorylation , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Protein Binding , Protein Structure, Tertiary , Protein-Tyrosine Kinases/metabolism , Thrombin/chemistry , Time Factors , Tyrosine/metabolism
3.
J Thromb Haemost ; 1(9): 2014-21, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12941045

ABSTRACT

Platelet adhesion to surface-bound fibrinogen depends on integrin alphaIIbbeta3. In the present study, we investigated the role of the regions 749EATSTFT756N and 755TNITYRG762T of the beta3 cytoplasmic tail in the regulation of platelet adhesion under flow conditions, by introducing peptide mimetics in platelets. Introduction of peptide EATSTFTN (E-N) increased surface coverage by 35%, an effect caused by 25% more adhesion. In contrast, peptide TNITYRGT (T-T) decreased surface coverage by 16%, as a result of 25% less adhesion. An S-->P substitution in the E-N peptide, thereby mimicking a mutation in Glanzmann's thrombasthenia, abolished the effect of E-N. A suboptimal concentration of cytochalasin D is known to enhance ligand binding to alphaIIbbeta3 in platelet suspensions. Under flow, cytochalasin D (1 micro mol L-1) induced 50% more platelet adhesion, with a strong reduction in platelet spreading. Both peptides opposed the increase in adhesion by cytochalasin D and partly (E-N) and completely (T-T) restored platelet spreading. Thus, the 749EATSTFT756N and 755TNITYRG762T regions of beta3 contribute to the regulation of alphaIIbbeta3 anchorage to the cytoskeleton and platelet spreading to an adhesive surface.


Subject(s)
Fibrinogen/metabolism , Integrin beta3/physiology , Platelet Adhesiveness , Platelet Glycoprotein GPIIb-IIIa Complex/physiology , Amino Acid Sequence/physiology , Amino Acid Substitution , Cytochalasin D/pharmacology , Cytoplasm , Cytoskeleton/metabolism , Humans , Integrin beta3/metabolism , Molecular Mimicry , Peptide Fragments/pharmacology , Perfusion , Platelet Adhesiveness/drug effects , Thrombasthenia/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...